Leading HIFU device in Mexico for Minimally Invasive Treatment for Prostate Cancer and Benign Prostatic Hyperplasia draws attention from elite urologists
CHARLOTTE, N.C., March 16 /PRNewswire/ -- Mexico HIFU in conjunction with International HIFU, the Mexican and international entities of USHIFU, a global leader in the development, manufacturing and distribution of high intensity focused ultrasound (HIFU) technologies, will host the very first multiday Sonablate(R) HIFU physician training seminar in Mexico City, March 17-18, 2009 at Hospital Star Medica Santa Fe.
The two day training seminar using the Sonablate(R) HIFU device will host top urologists from several of Mexico's leading hospitals, including the Angeles Hospital Group, Clinical Lomas Altas and Hospital Star Medica. The training seminar will include an academic presentation which will provide an overview of the physics and science of HIFU as a therapy for prostate cancer and also discuss patient selection. Additionally, the seminar will incorporate a comprehensive review of international clinical outcomes and advanced one-on-one simulator training. The highlight for physicians attending the seminar will be observation and participation in live Sonablate(R) HIFU cases.
"There has been significant interest from the urology community within Mexico to bring this technology to Mexico's largest city. Within two days of announcing the training seminar, the limited number of spots were filled and we now have a waiting list of doctors from Guadalajara and Monterrey for the next HIFU physician training seminar," said Alex Gonzalez, Vice President of International Operations, USHIFU. "We are ecstatic to be working with such high caliber physicians and continue to spread awareness about HIFU for prostate cancer throughout Mexico."
Although this is the first training program of its kind in Mexico City, in the past four years, over 1000 patients have been treated in Mexico with minimally invasive Sonablate(R) HIFU in Guadalajara, Monterrey, Mexico City, Puerto Vallarta and Cancun.
About the Sonablate(R) 500
The Sonablate(R) 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by FSI and is manufactured by Misonix, Inc. (Nasdaq: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate(R) 500 in Southeast Asia and the Middle East.
The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate cancer.
About Mexico HIFU & International HIFU
Mexico HIFU is affiliated with USHIFU and International HIFU, the entity through which USHIFU conducts its international business operations and makes the HIFU technologies available to patients at centers outside the United States.
About USHIFU, LLC
USHIFU is a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies.
|SOURCE US HIFU|
Copyright©2009 PR Newswire.
All rights reserved